Cat. No.: X24-08-YM060
Topoisomerase inhibitor, CL2-SN-38, Purity ≥98%
Synonym: 1036969-20-6; Cl2-SN-38 (dichloroacetic acid salt); [4-[[(2S)-6-Amino-2-[[(2S)-2-[[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[4-[[[4-[(2,5-dioxopyrrol-1-yl)methyl]cyclohexanecarbonyl]amino]methyl]triazol-1-yl]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethylamino]-2-oxoethoxy]acetyl]amino]-3-phenylpropanoyl]amino]hexanoyl]amino]phenyl]methyl [(19S)-10,19-diethyl-7-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-19-yl] carbonate
- CAS Number: 1036969-20-6
- Compound CID: 25139037
Product Size
1 mg; 5 mg; 10 mg; 50 mg
Properties
Description
CL2-SN-38 is an effective DNA damage inhibitor, that has the ability to prevent the pathway of DNA damage by inhibiting topoisomerase.
Molecular Formula
C83H107N11O23
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Stability
In its lyophilized form, the chemical remains stable for 36 months.
Quality Level
Research grade
Applications
CL2-SN-38 is a DNA damage inhibitor that plays a key role in increasing the concentration of SN-38 in tumor tissues.
Storage
Store at -20ºC, and keep desiccated.
Related Products
- Topoisomerase inhibitor, ABT-492, Purity ≥98%
- Topoisomerase inhibitor, Amonafide, Purity ≥98%
- Topoisomerase inhibitor, Camptothecin, Purity ≥98%
- Topoisomerase inhibitor, Gatifloxacin, Purity ≥98%
- Topoisomerase inhibitor, Idarubicin HCl, Purity ≥98%
- Topoisomerase inhibitor, Irinotecan, Purity ≥98%
